 Allogene Therapeutics, Inc. NASDAQ:ALLO Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Christine Cassiano Chief Communications Officer David Chang President and Chief Executive Officer Rafael Amado Executive Vice President-Research and Development and Chief Medical Officer Eric Schmidt Chief Financial Officer Conference Call Participants Tyler Van Buren Cowen Salveen Richter Goldman Sachs Michael Yee Jefferies Kelsey Goodwin Guggenheim Ren Benjamin JMP Securities Jason Gerberry Bank of America Mark Breidenbach Oppenheimer David Dai SMBC John Newman Canaccord Luca Issi RBC Capital Raju Prasad William Blair Asthika Goonewardene Truist Securities Kalpit Patel B. Riley Securities Jack Allen Baird Operator Hello, thank you for standing by. 